ClinicalTrials.Veeva

Menu

Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People

G

Greenyn Biotechnology

Status

Completed

Conditions

Fatigue Syndrome, Chronic
Cold

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Antrodia cinnamomea mycelia

Study type

Interventional

Funder types

Industry

Identifiers

NCT05728918
A-111-091

Details and patient eligibility

About

This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people.

Full description

This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people: a randomized, double-blind, placebo-controlled, and parallel clinical investigation.

Enrollment

25 patients

Sex

All

Ages

50 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects are easy to feel fatigued
  • Subjects have poor sleep quality

Exclusion criteria

  • Pregnant women or preparing for pregnancy.
  • Lactating women.
  • Women gave birth 6 months before the study.
  • Poor kindy and livers funcitons
  • Severe cardiovascular or other chronic diseases
  • Alcohol abuser
  • Using immune-associated supplements

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

25 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Placeo group
Treatment:
Dietary Supplement: Placebo
Treatment
Experimental group
Description:
Experimental group
Treatment:
Dietary Supplement: Antrodia cinnamomea mycelia

Trial contacts and locations

1

Loading...

Central trial contact

Ming-Shun Wu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems